These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 667820)

  • 21. A biochemical investigation of the adenovirus-induced G1 to S phase progression: thymidine kinase, ornithine decarboxylase, and inhibitors of polyamine biosynthesis.
    Cheetham BF; Bellett AJ
    J Cell Physiol; 1982 Feb; 110(2):114-22. PubMed ID: 7068769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-specific immune responsiveness of the tumor-bearing host.
    Burk MW; Yu S; McKhann CF
    Isr J Med Sci; 1976; 12(4-5):360-8. PubMed ID: 939694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of immunosuppressive factor(s) by a weakly immunogenic fibrosarcoma T 241.
    Gautam SC
    Anticancer Res; 1983; 3(4):263-8. PubMed ID: 6224458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice.
    Zietman AL; Suit HD; Ramsay JR; Silobrcic V; Sedlacek RS
    Cancer Res; 1988 Nov; 48(22):6510-6. PubMed ID: 3052803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of ornithine decarboxylase, tyrosine aminotransferase, and thymidine kinase by glucocorticoid in isolated, perfused liver after tumor inoculation.
    Sakata R
    Gan; 1975 Jun; 66(3):245-52. PubMed ID: 241680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
    Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
    J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma cell infiltrate of the primary tumor as a source of early systemic protection against metastases in mice.
    Vaage J; Pepin KG
    J Natl Cancer Inst; 1983 Jul; 71(1):147-55. PubMed ID: 6345879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.
    Suga T; Shiio T; Maeda YY; Chihara G
    Cancer Res; 1984 Nov; 44(11):5132-7. PubMed ID: 6488173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation or inhibition of immune resistance against metastatic or local growth of a C3H mammary carcinoma.
    Vaage J; Agarwal S
    Cancer Res; 1976 May; 36(5):1831-6. PubMed ID: 1268839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic cell therapy for a murine mammary carcinoma.
    Morecki S; Yacovlev E; Diab A; Slavin S
    Cancer Res; 1998 Sep; 58(17):3891-5. PubMed ID: 9731499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum therapy for radiation-induced impairment of immune resistance to metastasis.
    Vaage J; Agarwal S
    Cancer Res; 1977 Oct; 37(10):3556-60. PubMed ID: 908007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paradoxical effect of anthralin on 12-O-tetradecanoylphorbol-13-acetate-induced mouse epidermal ornithine decarboxylase activity, proliferation, and tumor promotion.
    De Young LM; Helmes CT; Chao WR; Young JM; Miller V
    Cancer Res; 1981 Jan; 41(1):204-8. PubMed ID: 7448761
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro induction of ornithine decarboxylase in urinary bladder carcinoma cells.
    Izumi K; Hirao Y; Hopp L; Oyasu R
    Cancer Res; 1981 Feb; 41(2):405-9. PubMed ID: 7448785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fetal growth modified by natural and induced changes in maternal reactivity.
    Breyere EJ
    Cancer Res; 1976 Sep; 36(9 PT 2):3441-5. PubMed ID: 975102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses.
    Brandes LJ; Arron RJ; Bogdanovic RP; Tong J; Zaborniak CL; Hogg GR; Warrington RC; Fang W; LaBella FS
    Cancer Res; 1992 Jul; 52(13):3796-800. PubMed ID: 1617649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.
    Verma AK; Ashendel CL; Boutwell RK
    Cancer Res; 1980 Feb; 40(2):308-15. PubMed ID: 6243250
    [No Abstract]   [Full Text] [Related]  

  • 37. Evidence that the local effect of ultraviolet radiation on the growth of murine melanomas is immunologically mediated.
    Donawho CK; Kripke ML
    Cancer Res; 1991 Aug; 51(16):4176-81. PubMed ID: 1678311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent data on the immunology of tumors. Mechanisms of escape of immunological control. Role of suppressor cells].
    Lespinats G; Poupon MF
    Bull Cancer; 1976; 63(2):269-78. PubMed ID: 1086690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inherent changes in the in vivo growth characteristics of C3H/He mammary carcinomas.
    Vaage J
    Cancer Res; 1980 Oct; 40(10):3495-3501. PubMed ID: 7438036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
    Gjedde SB
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.